medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2024, Number 6

<< Back Next >>

Acta Pediatr Mex 2024; 45 (6)

Maternal immunization as a protective factor for mother and child

Aguilar IF

Language: Spanish
References: 10
Page: 649-652
PDF size: 213.58 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Hye-Kyung Cho, Collrane Frivold, Helen Y Chu, MaternalImmunization, The Journal of Infectious Diseases, 2024;jiae509,https://doi.org/10.1093/infdis/jiae509

  2. Briga M, Goult E, Brett TS, Rohani P, Domenech de CellèsM. Maternal pertussis immunization and the blunting ofroutine vaccine effectiveness: a meta-analysis and modelingstudy. Nat Commun 2024; 15:921.

  3. Wilcox CR, Holder B, Jones CE. Factors Affecting theFcRn-Mediated Transplacental Transfer of Antibodies andImplications for Vaccination in Pregnancy. Front Immunol.2017 Oct 13; 8:1294. doi: 10.3389/fimmu.2017.01294.PMID: 29163461; PMCID: PMC5671757D

  4. Sahni LC, Olson SM, Halasa NB, et al. Maternal vaccineeffectiveness against influenza-associated hospitalizationsand emergency department visits in infants. JAMA Pediatr2024; 178:176–84.

  5. Simeone RM, Zambrano LD, Halasa NB, et al. OvercomingCOVID-19 investigators. Effectiveness of maternal mRNACOVID-19 vaccination during pregnancy against COVID-19-associated hospitalizations in infants aged <6 monthsduring SARS-CoV-2 Omicron predominance—20 states,March 9, 2022-May 31, 2023. MMWR Morb Mortal WklyRep 2023; 72:1057–64.

  6. https://www.gob.mx/salud/articulos/vacuna-contra-lainfluenza-estacional. Consultado el 31 de Octubre del 2024

  7. Simeone RM, Zambrano LD, Halasa NB, et al. Overcoming COVID-19 investigators. Effectiveness of maternal mRNA COVID-19vaccination during pregnancy against COVID- 19-associatedhospitalizations in infants aged <6 months during SARS-CoV-2Omicron predominance—20 states, March 9, 2022-May 31,2023. MMWR Morb Mortal Wkly Rep 2023; 72:1057–64.

  8. Guedalia J, Lipschuetz M, Cahen- Peretz A, et al. Maternalhybrid immunity and risk of infant COVID- 19 hospitalizations:national case-control study in Israel. Nat Commun2024; 15:2846.

  9. Kampmann B, Madhi SA, Munjal I, et al. Bivalent prefusionF vaccine in pregnancy to prevent RSV illness in infants. NEngl J Med 2023; 388: 1451–64.

  10. Dieussaert I, Kim JH, Luik S, et al. RSV prefusion F proteinbasedmaternal vaccine—preterm birth and other outcomes.N Engl J Med 2024; 390:1009–21




2020     |     www.medigraphic.com